Old Web
English
Sign In
Acemap
>
Paper
>
NIMG-22. HIGH-GRADE GLIOMA OUTCOMES IN THE PHASE 1 BXQ-350 TRIAL OF CANCER-SELECTIVE SapC-DOPS NANOVESICLES
NIMG-22. HIGH-GRADE GLIOMA OUTCOMES IN THE PHASE 1 BXQ-350 TRIAL OF CANCER-SELECTIVE SapC-DOPS NANOVESICLES
2018
Vinay K. Puduvalli
John L. Villano
Trisha M. Wise-Draper
John Morris
Olivier Rixe
Angela N. Johnson
Pierre Giglio
Jose Otero
Keywords:
SapC-DOPS Nanovesicles
Pathology
Cancer
Oncology
High-Grade Glioma
Medicine
Internal medicine
Karnofsky Performance Status
Glioma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]